Skip to main content
. 2022 Sep 26;23(19):11351. doi: 10.3390/ijms231911351

Figure 3.

Figure 3

Immunohistochemical evaluation of the proliferation rate of the target lesions by Ki-67 before and after treatment. Semiquantitative evaluation of Ki-67 before and after medical device 0.8% piroxicam and 50+ sunscreen, photodynamic therapy (PDT), and ingenol mebutate (IM) gel. * p < 0.01; ** p < 0.001.